These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25646792)

  • 1. Development and testing in healthy adults of oral hydrocortisone granules with taste masking for the treatment of neonates and infants with adrenal insufficiency.
    Whitaker MJ; Spielmann S; Digweed D; Huatan H; Eckland D; Johnson TN; Tucker G; Krude H; Blankenstein O; Ross RJ
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1681-8. PubMed ID: 25646792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency.
    Neumann U; Whitaker MJ; Wiegand S; Krude H; Porter J; Davies M; Digweed D; Voet B; Ross RJ; Blankenstein O
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):21-29. PubMed ID: 28815660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults.
    Melin J; Parra-Guillen ZP; Hartung N; Huisinga W; Ross RJ; Whitaker MJ; Kloft C
    Clin Pharmacokinet; 2018 Apr; 57(4):515-527. PubMed ID: 28762136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate-release granule formulation of hydrocortisone, Alkindi®, for treatment of paediatric adrenal insufficiency (Infacort development programme).
    Porter J; Withe M; Ross RJ
    Expert Rev Endocrinol Metab; 2018 May; 13(3):119-124. PubMed ID: 30058902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric population pharmacokinetic modelling to assess hydrocortisone replacement dosing regimens in young children.
    Michelet R; Melin J; Parra-Guillen ZP; Neumann U; Whitaker JM; Stachanow V; Huisinga W; Porter J; Blankenstein O; Ross RJ; Kloft C
    Eur J Endocrinol; 2020 Oct; 183(4):357-368. PubMed ID: 32621587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.
    Johannsson G; Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Biller BM; Monson JP; Stewart PM; Lennernäs H; Skrtic S
    J Clin Endocrinol Metab; 2012 Feb; 97(2):473-81. PubMed ID: 22112807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study.
    Johannsson G; Bergthorsdottir R; Nilsson AG; Lennernas H; Hedner T; Skrtic S
    Eur J Endocrinol; 2009 Jul; 161(1):119-30. PubMed ID: 19383806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
    Johannsson G; Lennernäs H; Marelli C; Rockich K; Skrtic S
    Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets.
    Simon N; Castinetti F; Ouliac F; Lesavre N; Brue T; Oliver C
    Clin Pharmacokinet; 2010 Jul; 49(7):455-63. PubMed ID: 20528006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
    Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
    BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.
    Mah PM; Jenkins RC; Rostami-Hodjegan A; Newell-Price J; Doane A; Ibbotson V; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):367-75. PubMed ID: 15355454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules.
    Neumann U; Braune K; Whitaker MJ; Wiegand S; Krude H; Porter J; Digweed D; Voet B; Ross RJM; Blankenstein O
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1433-e1440. PubMed ID: 32888021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a new formulation of sodium phenylbutyrate.
    Guffon N; Kibleur Y; Copalu W; Tissen C; Breitkreutz J
    Arch Dis Child; 2012 Dec; 97(12):1081-5. PubMed ID: 22941860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study.
    Chen L; Jiang X; Huang L; Lan K; Wang H; Hu L; Ren J; Li X; Zou Q
    Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence of single 100-mg doses of two oral formulations of topiramate: an open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteers.
    Piñeyro-López A; Piñeyro-Garza E; Gómez-Silva M; Reyes-Araiza R; Flores-Diego MA; Borrego-Alvarado S; Gamino-Peña ME; Vargas-Zapata R; Salazar-Leal ME
    Clin Ther; 2009 Feb; 31(2):411-7. PubMed ID: 19302913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.